MARKET

NAMS

NAMS

NewAmsterdam Pharma Company N.V
NASDAQ
29.86
-0.28
-0.93%
After Hours: 29.86 0 0.00% 16:10 03/06 EST
OPEN
29.45
PREV CLOSE
30.14
HIGH
30.44
LOW
29.00
VOLUME
1.04M
TURNOVER
--
52 WEEK HIGH
42.00
52 WEEK LOW
14.06
MARKET CAP
3.43B
P/E (TTM)
-17.3494
1D
5D
1M
3M
1Y
5Y
1D
Massive Insider Move at NewAmsterdam Pharma Shakes Up Investor Buzz
TipRanks · 6d ago
NewAmsterdam Highlights Obicetrapib Progress in Investor Presentation
TipRanks · 6d ago
Weekly Report: what happened at NAMS last week (0223-0227)?
Weekly Report · 6d ago
Top Executive Makes Bold Move With Major NewAmsterdam Pharma Stock Sale
TipRanks · 02/25 02:06
Interesting NAMS Put And Call Options For July 17th
NASDAQ · 02/23 15:40
Weekly Report: what happened at NAMS last week (0216-0220)?
Weekly Report · 02/23 10:15
Reaffirming Buy on NewAmsterdam Pharma: Optimized Expense Outlook and Milestone Upside Strengthen Risk‑Reward Profile
TipRanks · 02/21 01:45
NewAmsterdam Pharma Is Maintained at Buy by Guggenheim
Dow Jones · 02/19 14:42
More
About NAMS
NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.

Webull offers NewAmsterdam Pharma Company NV stock information, including NASDAQ: NAMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAMS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAMS stock methods without spending real money on the virtual paper trading platform.